Elsevier Medicinal Plant Biotechnology for Ameliorated Secondary Metabolite Production (Medicinal and Industrial Plants and Products)

Medicinal Plant Biotechnology for Ameliorated Secondary Metabolite Production delivers a cutting-edge perspective on how biotechnology is reshaping the way medicinal plants are studied and utilized. By integrating advanced molecular techniques, precision genetic tools, bioprocessing strategies, and analytical platforms, this volume addresses the critical challenge of enhancing the biosynthesis and optimization of high-value bioactive compounds. The book moves beyond technical innovation to emphasize its role in meeting global demand for plant-derived therapeutics while ensuring ecological balance. It highlights how advancements can drive sustainability, reduce reliance on synthetic alternatives, and open new pathways to ensure the long-term viability of plant genetic material and biodiversity preservation. This future-oriented approach makes the volume not just a specialized reference, but a strategic guide for shaping the next generation of plant-based functional solutions. Part of the Medicinal and Industrial Plants and Products series, this state-of-the-art resource boasts a holistic approach with relevance across stakeholders in academic and industrial contexts seeking practical insights that can be adapted to diverse plant species and scaled for real-world industrial and commercial uses. Offers a multidisciplinary overview bridging botanical, biotechnological, and pharmaceutical discoveries, enabling readers to connect fundamental plant science with practical solutions. Explores emerging trends such as genome editing, elicitor-based interventions, and nanotechnology, alongside conservation and metabolomic profiling. Demonstrates cross-sector applications in healthcare, nutrition, agriculture, and ecological stewardship, broadening the impact beyond traditional pharmaceutical contexts.